Related references
Note: Only part of the references are listed.Long-Term Prognosis of Unilateral and Multifocal Papillary Thyroid Microcarcinoma After Unilateral Lobectomy Versus Total Thyroidectomy
Ye Won Jeon et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Successful radiofrequency ablation strategies for benign thyroid nodules
Gee Mun Lee et al.
ENDOCRINE (2019)
Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study
Dengke Teng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology
Ji-hoon Kim et al.
KOREAN JOURNAL OF RADIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid
Makoto Tahara et al.
EUROPEAN JOURNAL OF CANCER (2017)
Differentiated Thyroid Cancer-Treatment: State of the Art
Benedikt Schmidbauer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
Angelica Schmidt et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2017)
Diagnostics and Treatment of Thyroid Carcinoma
Barbara Jarzab et al.
ENDOKRYNOLOGIA POLSKA (2016)
Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial
Marcia S. Brose et al.
LANCET ONCOLOGY (2016)
Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Treating Low-Risk Papillary Thyroid Microcarcinoma: A Prospective Study
Mingbo Zhang et al.
THYROID (2016)
Spanish consensus for the management of patients with advanced radioactive iodine refractory differentiated thyroid cancer
Garcilaso Riesco-Eizaguirre et al.
Endocrinologia y Nutricion (2015)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Marcia S. Brose et al.
LANCET (2014)
A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer
Athanassios Argiris et al.
INVESTIGATIONAL NEW DRUGS (2008)
Share Paper
